Transarterial radioembolization (TARE) is safe and can be an effective method of treatment for patients with intermediate or advanced-stage HCC that does not respond to transarterial chemoembolization (TACE). | Read More
A swivel arm can facilitate easier repositioning of the access arm during and after cone-beam computed tomography (CBCT) acquisition. Researchers reported their findings in the British Journal of Radiology. | Read More
Researchers compared outcomes in patients with single hypervascular hepatocellular carcinoma who were treated only with RFA versus those who were treated with a combination of percutaneous radiofrequency ablation (RFA) and transarterial chemoembolization (RFA/TACE). | Read More
Daniel Brown, MD, FSIR, offers advice on how to avoid potential problems when performing Y-90 procedures. | Read More
Before he started a four-week immersion with University of Utah Health’s Interventional Radiology team, 4th year medical student Wylie Foss didn’t have the clearest notion of what the specialty was. | Read More

Spotlight

Daniel Brown, MD, FSIR, offers advice on how to avoid potential problems when performing Y-90 procedures.
Daniel Sze, MD, PhD, discusses the results of SIRFLOX, FOXFIRE, and FOXFIRE Global trials and how continued investigations in this area, as well as in immunotherapy, may impact the field. Dr. Sze will be presenting at the 2018 Symposium on Clinical Interventional Oncology.
Daniel Brown, MD, FSIR, comments on the results of the FOXFIRE Global study and how results from future studies may lead to a paradigm shift for interventional oncology.